(function(){var loadHandler=window['sl_{07577339-214E-45D2-8349-B551DFC3D55F}'];loadHandler&&loadHandler(6, '<div id="spr0_538150c"><div id="spr1_538150c" class="kern"><img id="img2_538150c" src="data/img5.png" width="960px" height="540px" alt="" style="left:0px;top:0px;"/><div id="spr3_538150c" style="left:-3px;top:71px;"><img id="img0_538150c" src="data/img6.png" width="968" height="120" alt=""/></div><div id="spr4_538150c" style="left:0px;top:-0.625px;"><img id="img1_538150c" src="data/img7.png" width="961" height="156.326" alt=""/></div></div><div id="spr2_538150c" class="kern"><div id="spr5_538150c" style="left:48px;top:21.625px;"><div style="width:0px;"><span id="txt0_538150c" class="relpos" style="left:103.015px;top:-4.105px;">What should pathologist consider</span></div><div style="width:0px;"><span id="txt1_538150c" class="relpos" style="left:45.455px;top:39.095px;">for pathologic diagnosis of EUS-FNA/B?</span></div></div><div id="spr6_538150c" style="left:48px;top:133.922px;"><div style="width:0px;"><span id="txt2_538150c" class="nokern relpos" style="left:7.2px;top:4.911px;">•</span><span id="txt3_538150c" class="relpos" style="left:24.397px;top:5.041px;">Minimum requirement of tumor volume may depends upon</span></div><div style="width:0px;"><span id="txt4_538150c" class="relpos" style="left:34.2px;top:38.641px;">clinical setting &amp; pathologist experience</span></div><div style="width:0px;"><span id="txt5_538150c" class="nokern relpos" style="left:43.2px;top:77.684px;">–</span><span id="txt6_538150c" class="relpos" style="left:52.352px;top:77.795px;">Obvious mass with vascular invasion and/or distant metastasis: </span><span id="txt7_538150c" class="relpos" style="left:52.347px;top:77.795px;">small</span></div><div style="width:0px;"><span id="txt8_538150c" class="relpos" style="left:65.7px;top:106.595px;">volume may be enough</span></div><div style="width:0px;"><span id="txt9_538150c" class="nokern relpos" style="left:43.2px;top:141.044px;">–</span><span id="txt10_538150c" class="relpos" style="left:52.352px;top:141.155px;">Indeterminate clinical finding between malignancy &amp; benign stricture:</span></div><div style="width:0px;"><span id="txt11_538150c" class="relpos" style="left:65.7px;top:169.955px;">need more large volume of cytology</span></div><div style="width:0px;"><span id="txt12_538150c" class="nokern relpos" style="left:7.2px;top:205.551px;">•</span><span id="txt13_538150c" class="relpos" style="left:24.397px;top:205.681px;">Other parameter</span></div><div style="width:0px;"><span id="txt14_538150c" class="nokern relpos" style="left:43.2px;top:244.724px;">–</span><span id="txt15_538150c" class="relpos" style="left:52.352px;top:244.835px;">CCRT before procedure may induce more exaggerated cytologic atypia</span></div><div style="width:0px;"><span id="txt16_538150c" class="relpos" style="left:65.7px;top:273.635px;">(including normal fibroblast and/or endothelial cells)</span></div><div style="width:0px;"><span id="txt17_538150c" class="nokern relpos" style="left:43.2px;top:308.084px;">–</span><span id="txt18_538150c" class="relpos" style="left:52.352px;top:308.195px;">Is it repeated procedure or first one?</span></div></div></div></div>');})();